NYSEARCA:PPH

Vaneck Pharmaceutical Etf ETF News

etoro logo Buy PPH
*Your capital is at risk
$110.40
-1.20 (-1.08%)
At Close: Jul 31, 2026
Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the VanEck Pharmaceutical ETF (PPH) is a passively managed exchange traded fund launched on 12/20/2011.
This article will provide an in-depth analysis of drugs being developed to combat cancer. Big Pharma is keenly interested in the global cancer therapeutics market, which is expected to exceed $400 bil

PPH Is a Pertinent Healthcare Idea for 2025

09:47am, Thursday, 19'th Dec 2024
The healthcare sector is conspicuous in its absence from this year's bull market for stocks. As of Dec. 17, the S&P Health Care Select Sector Index was higher by just 3.2% since the start of the year
The VanEck Pharmaceutical ETF (PPH) was launched on 12/20/2011, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Pharma segment of the equity market
The VanEck Pharmaceutical ETF has shown strong performance but faces near-term downside risks, prompting a rating downgrade from buy to hold. PPH's valuation has increased significantly, with a high p

Healthcare ETFs Starting to Look Healthy

09:23am, Tuesday, 01'st Oct 2024
The healthcare sector hasn't been a bad performer, per se. Year-to-date, the S&P Health Care Select Sector Index is up 13.1%, but that lags the S&P 500 by 800 basis points, confirming investors have c
Blurring the lines between conference and festival, this year's Future Proof brought thousands of attendees to the summery shores of Huntington Beach in Los Angeles.
Looking for broad exposure to the Healthcare - Pharma segment of the equity market? You should consider the VanEck Pharmaceutical ETF (PPH), a passively managed exchange traded fund launched on 12/20/

This Pharma ETF Could Be Ideal Healthcare Pick

09:44am, Tuesday, 03'rd Sep 2024
Broadly speaking, the healthcare sector remains a laggard relative to the broader market. As of Aug. 28, the S&P Select Sector Health Care Index was trailing the S&P 500 by 310 basis points on a year-

Pharma ETFs in Focus Post Solid Q2 Earnings

12:51pm, Wednesday, 14'th Aug 2024
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.

Disruptive Theme of the Week: Playing Defense

08:39am, Wednesday, 14'th Aug 2024
When markets correct, it is a good time to revisit which equity market sectors are “defensive” themes. Certain products and services are nondiscretionary in nature that we cannot live without.

PPH: A Strong Fund To Play Big Pharma

03:19pm, Thursday, 18'th Jul 2024
The Health Care sector bullish due to AI technology. VanEck Pharmaceutical ETF offers exposure to leading pharmaceutical companies. The defensive nature of the pharmaceutical sector makes it somewhat
Launched on 12/20/2011, the VanEck Pharmaceutical ETF (PPH) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Pharma segment of the equity market.
The VanEck Pharmaceutical ETF (PPH) was launched on 12/20/2011, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Pharma segment of the equity market
Digging into the first quarter's earnings season allows us to uncover the winning themes of the period as captured by ETFs.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE